- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/32 - Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
Patent holdings for IPC class C07C 311/32
Total number of patents in this class: 40
10-year publication summary
|
1
|
3
|
3
|
3
|
2
|
3
|
3
|
3
|
4
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Board of Regents of the University of Texas System | 2204 |
5 |
| EA Pharma Co., Ltd. | 88 |
3 |
| Translate bio, Inc. | 415 |
3 |
| Board of Regents, The University of Texas System | 5786 |
2 |
| Eastman Chemical Company | 2216 |
2 |
| Epizyme, Inc. | 370 |
2 |
| AstraZeneca AB | 2920 |
1 |
| AstraZeneca UK Limited | 643 |
1 |
| Canon Inc. | 39818 |
1 |
| Kao Corporation | 4964 |
1 |
| President and Fellows of Harvard College | 5975 |
1 |
| AMOREPACIFIC Corporation | 2825 |
1 |
| Betta Pharmaceuticals Co., Ltd. | 179 |
1 |
| DyStar Textilfarben GmbH & Co. Deutschland KG | 35 |
1 |
| Galderma Research & Development | 404 |
1 |
| Modernatx, Inc. | 1261 |
1 |
| National University Corporation Kobe University | 525 |
1 |
| Sentinel Oncology Limited | 38 |
1 |
| Universidad Complutense de Madrid | 209 |
1 |
| University of Tsukuba | 613 |
1 |
| Other owners | 9 |